11/19
07:25 am
athe
Alterity Therapeutics Appoints Abby Macnish Niven as Company Secretary
Low
Report
Alterity Therapeutics Appoints Abby Macnish Niven as Company Secretary
11/12
07:49 am
athe
Alterity Therapeutics Announces Presentation on Tracking the Progression of Multiple System Atrophy at International Symposium [Yahoo! Finance]
Low
Report
Alterity Therapeutics Announces Presentation on Tracking the Progression of Multiple System Atrophy at International Symposium [Yahoo! Finance]
11/12
07:35 am
athe
Alterity Therapeutics Announces Presentation on Tracking the Progression of Multiple System Atrophy at International Symposium
Neutral
Report
Alterity Therapeutics Announces Presentation on Tracking the Progression of Multiple System Atrophy at International Symposium
11/6
07:35 am
athe
Alterity Therapeutics Announces New Publication Describing Novel Mechanism of Action for ATH434
High
Report
Alterity Therapeutics Announces New Publication Describing Novel Mechanism of Action for ATH434
10/31
07:41 am
athe
Appendix 4C – Q1 FY25 Quarterly Cash Flow Report [Yahoo! Finance]
Low
Report
Appendix 4C – Q1 FY25 Quarterly Cash Flow Report [Yahoo! Finance]
10/31
07:35 am
athe
Appendix 4C – Q1 FY25 Quarterly Cash Flow Report
Low
Report
Appendix 4C – Q1 FY25 Quarterly Cash Flow Report
10/14
07:38 am
athe
Alterity Therapeutics to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit on 17 October 2024 [Yahoo! Finance]
Low
Report
Alterity Therapeutics to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit on 17 October 2024 [Yahoo! Finance]
10/14
07:35 am
athe
Alterity Therapeutics to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit on 17 October 2024
Low
Report
Alterity Therapeutics to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit on 17 October 2024
10/11
07:35 am
athe
Alterity Therapeutics Announces Presentation of New Data Describing Neuroprotection of ATH434 at Neuroscience Meeting
Low
Report
Alterity Therapeutics Announces Presentation of New Data Describing Neuroprotection of ATH434 at Neuroscience Meeting
10/2
07:49 am
athe
Alterity Therapeutics Raises Profile with Multiple Data Presentations at the International Congress of Parkinson's Disease and Movement Disorders® [Yahoo! Finance]
Low
Report
Alterity Therapeutics Raises Profile with Multiple Data Presentations at the International Congress of Parkinson's Disease and Movement Disorders® [Yahoo! Finance]
10/2
07:35 am
athe
Alterity Therapeutics Raises Profile with Multiple Data Presentations at the International Congress of Parkinson’s Disease and Movement Disorders®
Medium
Report
Alterity Therapeutics Raises Profile with Multiple Data Presentations at the International Congress of Parkinson’s Disease and Movement Disorders®
9/30
08:11 am
athe
Alterity Therapeutics appoints Abby Macnish Niven as CFO [Seeking Alpha]
Low
Report
Alterity Therapeutics appoints Abby Macnish Niven as CFO [Seeking Alpha]
9/30
07:41 am
athe
Alterity Therapeutics Appoints Abby Macnish Niven as Chief Financial Officer [Yahoo! Finance]
Low
Report
Alterity Therapeutics Appoints Abby Macnish Niven as Chief Financial Officer [Yahoo! Finance]
9/30
07:35 am
athe
Alterity Therapeutics Appoints Abby Macnish Niven as Chief Financial Officer
Low
Report
Alterity Therapeutics Appoints Abby Macnish Niven as Chief Financial Officer
9/23
07:59 am
athe
Alterity Therapeutics to Deliver Multiple Oral and Poster Presentations at the International Congress of Parkinson's Disease and Movement Disorders® [Yahoo! Finance]
Low
Report
Alterity Therapeutics to Deliver Multiple Oral and Poster Presentations at the International Congress of Parkinson's Disease and Movement Disorders® [Yahoo! Finance]
9/23
07:35 am
athe
Alterity Therapeutics to Deliver Multiple Oral and Poster Presentations at the International Congress of Parkinson’s Disease and Movement Disorders®
Low
Report
Alterity Therapeutics to Deliver Multiple Oral and Poster Presentations at the International Congress of Parkinson’s Disease and Movement Disorders®